Search

Author/Creator Mikhael, Joseph R.

1. A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR‐CD) for untreated low‐grade non‐Hodgkin lymphoma requiring therapy. Issue 5 (22nd March 2017)

Authors:
Rosenthal, Allison; Dueck, Amylou C.; Ansell, Stephen; Gano, Katherine; Conley, Christopher; Nowakowski, Grzegorz S.; Camoriano, John; Leis, Jose F.; Mikhael, Joseph R.; Keith Stewart, A.; Inwards, David; Dingli, David; Kumar, Shaji; Noel, Pierre; Gertz, Morie; Porrata, Luis; Russell, Stephen; Co...
Journal:
American journal of hematology
Issue:
Volume 92:Issue 5(2017:May)
Page Start:
467
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. AT‐101 downregulates BCL2 and MCL1 and potentiates the cytotoxic effects of lenalidomide and dexamethasone in preclinical models of multiple myeloma and Waldenström macroglobulinaemia. (17th November 2013)

Authors:
Paulus, Aneel; Chitta, Kasyapa; Akhtar, Sharoon; Personett, David; Miller, Kena C.; Thompson, Kevin J.; Carr, Jennifer; Kumar, Shaji; Roy, Vivek; Ansell, Stephen M.; Mikhael, Joseph R.; Dispenzieri, Angela; Reeder, Craig B.; Rivera, Candido E.; Foran, James; Chanan‐Khan, Asher
Journal:
British journal of haematology
Issue:
Volume 164:Number 3(2014:Feb.)
Page Start:
352
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Autologous stem cell transplant is an effective therapy for carefully selected patients with AL amyloidosis: experience of a single institution. (25th November 2013)

Authors:
Jimenez‐Zepeda, Victor H.; Franke, Norman; Reece, Donna E.; Trudel, Suzanne; Chen, Christine; Delgado, Diego H.; Winter, Andrew; Mikhael, Joseph R.; Tiedemann, Rodger; Kukreti, Vishal
Journal:
British journal of haematology
Issue:
Volume 164:Number 5(2014:Mar.)
Page Start:
722
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma. Issue 5 (10th March 2017)

Authors:
Bennani, N. Nora; LaPlant, Betsy R.; Ansell, Stephen M.; Habermann, Thomas. M.; Inwards, David J.; Micallef, Ivana N.; Johnston, Patrick B.; Porrata, Luis F.; Colgan, Joseph P.; Markovic, Svetomir N.; Nowakowski, Grzegorz S.; Macon, William R.; Reeder, Craig B.; Mikhael, Joseph R.; Northfelt, Don...
Journal:
American journal of hematology
Issue:
Volume 92:Issue 5(2017:May)
Page Start:
448
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Long‐term survival with cyclophosphamide, bortezomib and dexamethasone induction therapy in patients with newly diagnosed multiple myeloma. (30th June 2014)

Authors:
Reeder, Craig B.; Reece, Donna E.; Kukreti, Vishal; Mikhael, Joseph R.; Chen, Christine; Trudel, Suzanne; Laumann, Kristina; Vohra, Harjot; Fonseca, Rafael; Bergsagel, P. Leif; Leis, Jose F.; Tiedemann, Rodger; Stewart, A. Keith
Journal:
British journal of haematology
Issue:
Volume 167:Number 4(2014:Nov.)
Page Start:
563
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Phase I/II study of the novel proteasome inhibitor delanzomib (CEP-18770) for relapsed and refractory multiple myeloma. Issue 8 (3rd August 2017)

Authors:
Vogl, Dan T.; Martin, Thomas G.; Vij, Ravi; Hari, Parameswaran; Mikhael, Joseph R.; Siegel, David; Wu, Ka Lung; Delforge, Michel; Gasparetto, Cristina
Journal:
Leukemia & lymphoma
Issue:
Volume 58:Issue 8(2017)
Page Start:
1872
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Phase Ib/II trial of CYKLONE (cyclophosphamide, carfilzomib, thalidomide and dexamethasone) for newly diagnosed myeloma. (13th February 2015)

Authors:
Mikhael, Joseph R.; Reeder, Craig B.; Libby, Edward N.; Costa, Luciano J.; Bergsagel, P. Leif; Buadi, Francis; Mayo, Angela; Nagi Reddy, Sravan K.; Gano, Katherine; Dueck, Amylou C.; Stewart, A. Keith
Journal:
British journal of haematology
Issue:
Volume 169:Number 2(2015:Apr.)
Page Start:
219
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Phase I‐II trial of oral cyclophosphamide, prednisone and lenalidomide for the treatment of patients with relapsed and refractory multiple myeloma. (22nd August 2014)

Authors:
Reece, Donna E.; Masih‐Khan, Esther; Atenafu, Eshetu G.; Jimenez‐Zepeda, Victor H.; Anglin, Peter; Chen, Christine; Kukreti, Vishal; Mikhael, Joseph R.; Trudel, Suzanne
Journal:
British journal of haematology
Issue:
Volume 168:Number 1(2015:Jan.)
Page Start:
46
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗